Talc Pleurodesis Ct

chapter 29

figure 29.21. A 26-year-old woman with previous history of talc pleurodesis for malignant pleural effusion. (A) FDG-PET scan shows areas of increased uptake in the pleural space (arrows). (B) Correlative CT scan (soft tissue windows) shows increased attenuation

(arrows) in the pleural space consistent with talc deposits. The patient had no clinical evidence for recurrence, and her PET and CT scans were stable over 3 years.

References

1. Fry WA, Menck HR, Winchester DP. The National Cancer Data Base report on lung cancer. Cancer (Phila) 1996;77:1947-1955.

2. Berlin NI, Buncher CR, Fontana RS, et al. The National Cancer Institute Cooperative Early Lung Cancer Detection Program. Am Rev Respir Dis 1984;130:545-549.

3. Frost JK, Ball WC Jr, Levin ML, et al. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in The Johns Hopkins study. Am Rev Respir Dis 1984; 130:549-554.

4. Melamed MR, Flehinger BJ, Zaman MB, et al. Screening for early lung cancer: results of the initial (prevalence) radiologic and cytologic screening in the Memorial Sloan-Kettering study. Chest 1984;86:44-53.

5. Fontana RS, Sanderson DR, Woolner LB, et al. Screening for lung cancer. A critique of the Mayo lung project. Cancer (Phila) 1991; 67:1155-1164.

6. Strauss GM, Gleason RE, Sugarbaker DJ. Screening for lung cancer re-examined. A reinterpretation of the Mayo lung project randomized trial on lung cancer screening. Chest 1993;103:337S-341S.

7. Manser RL, Irving LB, Byrnes G, et al. Screening for lung cancer: a systematic review and meta-analysis of controlled trials. Thorax 2003;58:784-789.

8. Henschke CI, McCauley DI, Yankelevitz DF, et al. Early lung cancer action project: overall design and findings from baseline screening. Lancet 1999;354:99-105.

9. Henschke CI, Maidich DP, Yankelevitz DF, et al. Early lung cancer action project: initial findings on repeat screenings. Cancer (Phila) 2001;92:153-159.

10. Siegelman SS, Khouri NF, Leo FP, et al. Solitary pulmonary nodules: CT assessment. Radiology 1986;160:307-312.

11. Hasegawa M, Sone S, Takashima S, et al. Growth rate of small lung cancers detected on mass CT screening. Br J Radiol 2000; 73:1252-1259.

12. Mirtcheva RM, Vazquez M, Yankelevitz DF, et al. Bronchi-oloalveolar carcinoma and adenocarcinoma with bronchi-oloalveolar features presenting as ground-glass opacities on CT. J Clin Imaging 2002;26:95-100.

13. Gaeta M, Caruso R, Barone M, et al. Ground-glass attenuation in nodular bronchioloalveolar carcinoma: CT patterns and prognostic value. J Comput Assist Tomogr 1998;22:215-219.

14. Henschke CI, Yankelevitz DF, Mirtcheva R, et al. CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules. AJR Am J Roentgenol 2002;178:1053-1057.

15. Kim EA, Johkoh T, Lee KS, et al. Quantification of ground-glass opacity on high-resolution CT of small peripheral adenocarci-noma of the lung: pathologic and prognostic implications. AJR Am J Roentgenol 2001;177:1417-1422.

16. Asamura H, Suzuki K, Watanabe S, et al. A clinicopathological study of resected subcentimeter lung cancers: a favorable prognosis for ground glass opacity lesions. Ann Thorac Surg 2003; 76:1016-1022.

17. Sider L. Radiographic manifestations of primary bronchogenic carcinoma. Radiol Clin N Am 1990;28:583-597.

18. Rosado de Christenson ML, Templeton PA, Moran CA. Bron-chogenic carcinoma: radiologic-pathologic correlation. Radio-Graphics 1994;14:429-446.

19. Golden R. The effect of bronchostenosis upon the roentgen-ray shadows in carcinoma of the bronchus. Am J Roentgenol 1925; 13:21-30.

20. Im JG, Hann MC, Yu EJ, et al. Lobar bronchioloalveolar carcinoma: "angiogram sign" on CT scans. Radiology 1990;176:749-753.

21. Shah RM, Friedman AC. CT angiogram sign: incidence and significance in lobar consolidations evaluated by contrast-enhanced CT. AJR Am J Roentgenol 1998;170:719-721.

22. Murayama S, Onitsuka H, Murakami J, et al. "CT angiogram sign" in obstructive pneumonitis and pneumonia. J Comput Assist Tomogr 1993;17:609-612.

23. Aquino SL, Chiles C, Halford P. Distinction of consolidative bronchioloalveolar carcinoma from pneumonia: do CT criteria work? AJR Am J Roentgenol 1998;171:359-363.

24. Jung JI, Kim H, Park SH, et al. CT differentiation of pneumonic-type bronchioloalveolar cell carcinoma and infectious pneumonia. Br J Radiol 2001;74:490-494.

25. Johnson DE, Goldberg M. Management of carcinoma of the superior pulmonary sulcus. Oncology 1997;11:781-765; discussion 785-786.

26. O'Connell RS, McLoud TC, Wilkins EW. Superior sulcus tumor: radiographic diagnosis and workup. AJR Am J Roentgenol 1983; 140:25-30.

27. Renner RR, Pernice NJ. The apical cap. Semin Roentgenol 1977; 12:299-302.

28. Takasugi JE, Rapoport S, Shaw C. Superior sulcus tumors: the role of imaging. J Thorac Imaging 1989;4:41-48.

29. Heelan RT, Demas BE, Caravelli JF, et al. Superior sulcus tumors: CT and MR imaging. Radiology 1989;170:637-641.

30. Laissy JP, Soyer P, Sekkal SR, et al. Assessment of vascular involvement with magnetic resonance angiography (MRA) in Pancoast syndrome. Magn Reson Imaging 1995;13:523-530.

31. Pieterman RM, van Putten JWG, Meuzelaar JJ, et al. Preoperative staging of non-small-cell lung cancer with positronemission tomography. N Engl J Med 2000;343:254-261.

32. Lardinois D, Weder W, Hany TF, et al. Staging of non-small cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003;348:2500-2507.

33. Aquino SL, Asmuth JC, Moore RH, et al. Improved image interpretation with registered thoracic CT and positron emission tomography data sets. AJR Am J Roentgenol 2002;178:939-944.

34. Kang JH, Kim KD, Chung KY. Prognostic value of visceral pleura invasion in non-small cell lung cancer. Eur J Cardiothorac Surg 2003;23:865-869.

35. Manac'h D, Riquet M, Medioni J, et al. Visceral pleura invasion by non-small cell lung cancer: an underrated bad prognostic factor. Ann Thorac Surg 2001;71:1088-1093.

36. Glazer HS, Duncan-Meyer J, Aronberg DJ, et al. Pleural and chest wall invasion in bronchogenic carcinoma: CT evaluation. Radiology 1985;157:191-194.

37. Padovani B, Mouroux J, Seksik L, et al. Chest wall invasion by bronchogenic carcinoma: evaluation with MR imaging. Radiology 1993;187:33-38.

38. Ratto GB, Piacenza G, Frola C, et al. Chest wall involvement by lung cancer: computed tomographic detection and results of operation. Ann Thorac Surg 1991;51:182-188.

39. Pennes DR, Glazer GM, Wimbish KJ, et al. Chest wall invasion by lung cancer: limitations of CT evaluation. AJR Am J Roentgenol 1985;144:507-511.

40. Pearlberg JL, Sandler MA, Beute GH, et al. Limitations of CT in evaluation of neoplasms involving chest wall. J Comput Assist Tomogr 1987;11:290-293.

41. Scott IR, Müller NL, Miller RR, et al. Resectable Stage III lung cancer: CT, surgical, and pathologic correlation. Radiology 1988; 166(1 pt 1):75-79.

42. Uhrmeister P, Allmann KH, Wertzel H, et al. Chest wall infiltration by lung cancer: value of thin-sectional CT with different reconstruction algorithms. Eur Radiol 1999;9:1304-1309.

43. Shiotani S, Sugimura K, Sugihara M, et al. Diagnosis of chest wall invasion by lung cancer: useful criteria for exclusion of the possibility of chest wall invasion with MR imaging. Radiat Med 2000;18:283-290.

44. Sakai S, Murayama S, Murakami J, et al. Bronchogenic carcinoma invasion of the chest wall: evaluation with dynamic cine MRI during breathing. J Comput Assist Tomogr 1997;21:595-600.

45. Toloza EM, Harpole L, McCrory DC. Noninvasive staging of non-small cell lung cancer. Chest 2003;123(suppl 1):137S-146S.

46. Dales RE, Stark RM, Raman S. Computed tomography to stage lung cancer. Approaching a controversy using meta-analysis. Am Rev Respir Dis 1990;141:1096-1101.

47. Gould MK, Kuschner WG, Rydzak CE, et al. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer. Ann Intern Med 2003;139:879-892.

48. Graeter TP, Hellwig D, Hoffmann K, et al. Mediastinal lymph node staging in suspected lung cancer: comparison of positron emission tomography with F-18-fluorodeoxyglucose and mediastinoscopy. Ann Thorac Surg 2003;75:231-236.

49. Vansteenkiste JF, Stroobants SG, DeLeyn De Leyn PR, et al. Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients. J Clin Oncol 1998;16:2142-2149.

50. Albes JM, Lietzenmayer R, Schott U, et al. Improvement of non-small-cell lung cancer staging by means of positron emission tomography. Thorac Cardiovasc Surg 1999;47:42-47.

51. Berlangieri SU, Scott AM, Knight SR, et al. F-18 fluo-rodeoxyglucose positron emission tomography in the noninvasive staging of non-small cell lung cancer. Eur J Cardiothorac Surg 1999;16(suppl 1):S25-S30.

52. Chin R Jr, Ward R, Keyes JW, et al. Mediastinal staging of non-small-cell lung cancer with positron emission tomography. Am J Respir Crit Care Med 1995;152:2090-2096.

53. Cerfolio RJ, Ojha B, Bryant AS, et al. The role of FDG-PET scan in staging patients with nonsmall cell carcinoma. Ann Thorac Surg 2003;76:861-866.

54. Pfister DG, Johnson DH, Azzoli CG, et al. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. J Clin Oncol 2004;22:330-353.

55. Dunagan DP, Chin R Jr, McCain TW, et al. Staging by positron emission tomography predicts survival in patients with non-small cell lung cancer. Chest 2001;119:333-339.

56. Hicks RJ, Kalff V, MacManus MP, et al. 18F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non-small cell lung cancer. J Nucl Med 2001; 42:1596-1604.

57. Vansteenkiste JF, Stroobants SG, Dupont RJPJ, et al. FDG-PET scan in potentially operable non-small cell lung cancer: do anatometabolic PET-CT fusion images improve the localization of regional lymph node metastases? The Leuven Lung Cancer Group. Eur J Nucl Med 1998;25:1495-1501.

58. Magnani P, Carretta A, Rizzo G, et al. FDG/PET and spiral CT image fusion for mediastinal lymph node assessment on non-small cell lung cancer patients. J Cardiovasc Surg 1999;40:741-748.

59. Beyer T, Townsend DW, Brun T, et al. A combined PET/CT scanner for clinical oncology. Results of the initial screen (prevalence). Early lung cancer detection: introduction. J Nucl Med 2000;41:1369-1379.

60. Antoch G, Stattaus J, Nemat AT, et al. Non-small cell lung cancer: dual-modality PET/CT in preoperative staging. Radiology 2003;229:526-533.

61. Ries LAG, Eisner MP, Kosary CL, et al. (eds). SEER Cancer Statistics Review, 1975-2000. Bethesda, MD: National Cancer Institute. http://seer.cancer.gov/csr/1975_2000, 2003.

62. Vaaler AK, Forrester JM, Lesar M, et al. Obstructive atelectasis in patients with small cell lung cancer. Incidence and response to treatment. Chest 1997;111:115-120.

63. Schumacher T, Brink I, Mix M, et al. FDG-PET imaging for the staging and follow-up of small cell lung cancer. Eur J Nucl Med 2001;28:483-488.

64. Pandit N, Gonen M, Krug L, et al. Prognostic value of [18F] FDG-PET imaging in small cell lung cancer. Eur J Nucl Med 2003; 30:78-84.

65. Choi JB, Park CK, Park DW, et al. Does contrast enhancement on CT suggest tumor response for chemotherapy in small cell carcinoma of the lung. J Comput Assist Tomogr 2002;26:797-800.

66. Perez EA, Loprinzi CL, Sloan JA, et al. Utility of screening procedures for detecting recurrence of disease after complete response in patients with small cell lung carcinoma. Cancer (Phila) 1997;80:676-680.

67. Rea F, Binda R, Spreafico G, et al. Bronchial carcinoids: a review of 60 patients. Ann Thorac Surg 1989;47:412-414.

68. Harpole DH Jr, Feldman JM, Buchanan S, et al. Bronchial carcinoid tumors: a retrospective analysis of 126 patients. Ann Thorac Surg 1992;54:50-54; discussion 54-55.

69. Jeung MY, Gasser B, Gangi A, et al. Bronchial carcinoid tumors of the thorax: spectrum of radiologic findings. RadioGraphics 2002;22:351-365.

70. Forster BB, Muller NL, Miller RR, et al. Neuroendocrine carcinomas of the lung: clinical, radiologic, and pathologic correlation. Radiology 1989;170:441-445.

71. Magid D, Siegelman SS, Eggleston JC, et al. Pulmonary carcinoid tumors: CT assessment. J Comput Assist Tomogr 1989;13:244-247.

72. Zwiebel BR, Austin JH, Brimes MM. Bronchial carcinoid tumors: assessment with CT of location and intratumoral calcification in 31 patients. Radiology 1991;179:483-486.

73. Aronchick JM, Wexler JA, Christen B, et al. Computed tomography of bronchial carcinoid. J Comput Assist Tomogr 1986;10: 71-74.

74. Choplin RH, Kawamoto EH, Dyer RB, et al. Atypical carcinoid of the lung: radiographic features. AJR Am J Roentgenol 1986; 146:665-668.

75. Douek PC, Simoni L, Revel D, et al. Diagnosis of bronchial carcinoid tumor by ultrafast contrast-enhanced MR imaging. AJR Am J Roentgenol 1994;163:563-564.

76. Erasmus, JJ, McAdams HP, Patz EF Jr, et al. Evaluation of primary pulmonary carcinoid tumors using FDG PET. AJR Am J Roentgenol 1998;170:1369-1373.

77. Gould PM, Bonner JA, Sawyer TE, et al. Bronchial carcinoid tumors: importance of prognostic factors that influence patterns of recurrence and overall survival. Radiology 1998;208:181-185.

78. King CM, Reznek RH, Bomanji J, et al. Imaging neuroendocrine tumours with radiolabelled somatostatin analogues and x-ray computed tomography: a comparative study. Clin Radiol 1993; 48:386-391.

79. Kawashima A, Libshitz HI. Malignant pleural mesothelioma: CT manifestations in 50 cases. AJR Am J Roentgenol 1990;155: 965-969.

80. Metintas M, Ucgun I, Elbek O, et al. Computed tomography features in malignant pleural mesothelioma and other commonly seen pleural diseases. Eur J Radiol 2002;41:1-9.

81. Knuuttila A, Halme M, Kivisaari L, et al. The clinical importance of magnetic resonance imaging versus computed tomography in malignant pleural mesothelioma. Lung Cancer 1998;22: 215-225.

82. Knuuttila A, Kivisaari L, Kivisaari A, et al. Evaluation of pleural disease using MR and CT. With special reference to malignant pleural mesothelioma. Acta Radiol 2001;42:502-507.

83. Heelan RT, Rusch VW, Begg CB, et al. Staging of malignant pleural mesothelioma: comparison of CT and MR imaging. AJR Am J Roentgenol 1999;172:1039-1047.

84. Benard F, Sterman D, Smith R, et al. Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography. Chest 1998;114:713-722.

85. Gerbaudo VH, Sugarbaker DJ, Britz-Cunningham S, et al. Assessment of malignant pleural mesothelioma with 18F-FDG dual-head gamma-camera coincidence imaging: comparison with histopathology. J Nucl Med 2002;43:1144-1149.

86. Flores RA, Akhurst TB, Gonen MC, et al. Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2003;126:11-16.

87. Kim YH, Lee KS, Primack SL, et al. Small pulmonary nodules on CT accompanying surgically resectable lung cancer: likelihood of malignancy. J Thorac Imaging 2002;17:40-46.

88. Chalmers N, Best JJ. The significance of pulmonary nodules detected by CT but not by chest radiography in tumour staging. Clin Radiol 1991;44:410-412.

89. Kronawitter U, Kemeny NE, Heelan R, et al. Evaluation of chest computed tomography in the staging of patients with potentially resectable liver metastases from colorectal carcinoma. Cancer (Phila) 1999;86:229-235.

90. Povoski SP, Fong Y, Sgouros SC, et al. Role of chest CT in patients with negative chest x-rays referred for hepatic colorec-tal metastases. Ann Surg Oncol 1998;5:9-15.

91. Picci P, Vanel D, Briccoli A, et al. Computed tomography of pulmonary metastases from osteosarcoma: the less poor technique. A study of 51 patients with histological correlation. Ann Oncol 2001;12:1601-1604.

92. Fernandez EB, Colon E, McLeod DG, et al. Efficacy of radiographic chest imaging in patients with testicular cancer. Urology 1994;44:243-248; discussion 248-249.

93. Lim DJ, Carter MF. Computerized tomography in the preoperative staging for pulmonary metastases in patients with renal cell carcinoma. J Urol 1993;150:1112-1114.

94. Warner G, Cox G. Evaluation of chest radiography versus chest computed tomography in screening for pulmonary malignancy in advanced head and neck cancer. J Otolaryngol 2003;32:107-109.

95. Heaston DK, Putman CE, Rodan BA, et al. Solitary pulmonary metastases in high-risk melanoma patients: a prospective comparison of conventional and computed tomography. AJR Am J Roentgenol 1983;141:169-174.

96. Reiner B, Siegel E, Sawyer R, et al. The impact of routine CT of the chest on the diagnosis and management of newly diagnosed squamous cell carcinoma of the head and neck. AJR Am J Roentgenol 1997;169:667-671.

97. Yamada H, Katoh H, Kondo S, et al. Surgical treatment of pulmonary recurrence after hepatectomy for colorectal liver metastases. Hepatogastroenterology 2002;49:976-979.

98. Koong HN, Pastorino U, Ginsberg RJ. Is there a role for pneumonectomy in pulmonary metastases? Ann Thorac Surg 1999; 68:2039-2043.

99. Al-Mehdi AB, Tozawa K, Fisher AB, et al. Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis. Nat Med 2000;6:100-102.

100. Wong CW, Song C, Grimes MM, et al. Intravascular location of breast cancer cells after spontaneous metastasis to the lung. Am J Pathol 2002;161:749-753.

101. Milne EN, Zerhouni EA. Blood supply of pulmonary metastases. J Thorac Imaging 1987;2:15-23.

102. Stackpole CW. Intrapulmonary spread of established B16 melanoma lung metastases and lung colonies. Invasion Metastasis 1990;10:267-280.

103. Alterman AL, Fornabaio DM, Stackpole CW. Metastatic dissemination of B16 melanoma: pattern and sequence of metastasis. J Natl Cancer Inst 1985;75:691-702.

104. Cahan WG, Shah JP, Castro EB. Benign solitary lung lesions in patients with cancer. Ann Surg 1978;187:241-244.

105. Schlumberger M, Arcangioli O, Piekarski JD, et al. Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest X-rays. J Nucl Med 1988; 29:1790-1794.

106. Piekarski JD, Schlumberger M, Leclere J, et al. Chest computed tomography (CT) in patients with micronodular lung metastases of differentiated thyroid carcinoma. Int J Radiat Oncol Biol Phys 1985;11:1023-1027.

107. Lee K, Kim T, Han J, et al. Diffuse micronodular lung disease: HRCT and pathologic findings. J Comput Assist Tomogr 1999; 23:99-106.

108. Hirakata K, Nakata H, Haratake J. Appearance of pulmonary metastases on high-resolution CT scans: comparison with histopathologic findings from autopsy specimens. AJR Am J Roentgenol 1993;161:37-43.

109. Primack SL, Hartman TE, Lee KS, et al. Pulmonary nodules and the CT halo sign. Radiology 1994;190:513-515.

110. Patel A, Ryu J. Angiosarcoma in the lung. Chest 1993;103:1531-1535.

111. Benditt JO, Farber HW, Wright J, et al. Pulmonary hemorrhage with diffuse alveolar infiltrates in men with high-volume choriocarcinoma. Ann Intern Med 1988;109:674-675.

112. Gaeta M, Blandino A, Scribano E, et al. Computed tomography halo sign in pulmonary nodules: frequency and diagnostic value. J Thorac Imaging 1999;14:109-113.

113. Sidhu GS, Wieczorek R, Cassai ND, et al. The concept of bron-chioloalveolar cell adenocarcinoma: redefinition, a critique of the 1999 WHO classification, and an ultrastructural analysis of 155 cases. Int J Surg Pathol 2003;11:89-99.

114. de Santos LA, Lindell MM Jr, Goldman AM, et al. Calcification within metastatic pulmonary nodules from synovial sarcoma. Orthopedics 1978;1:141-144.

115. Cockshott WP, Hendrickse JP. Pulmonary calcification at the site of trophoblastic metastases. Br J Radiol 1969;42:17-20.

116. Hall FM, Frank HA, Cohen RB, et al. Ossified pulmonary metastases from giant cell tumor of bone. AJR Am J Roentgenol 1976; 127:1046-1047.

117. Jimenez JM, Casey SO, Citron M, et al. Calcified pulmonary metastases from medullary carcinoma of the thyroid. Comput Med Imaging Graph 1995;19:325-328.

118. Franchi M, La Fianza A, Babilonti L, et al. Serous carcinoma of the ovary: value of computed tomography in detection of calcified pleural and pulmonary metastatic implants. Gynecol Oncol 1990;39:85-88.

119. Rosenfield AT, Sanders RC, Custer LE. Widespread calcified metastases from adenocarcinoma of the jejunum. Am J Dig Dis 1975;20:990-993.

120. Chaudhuri MR. Cavitary pulmonary metastases. Thorax 1970; 25:375-381.

121. Dodd GD, Boyle JJ. Excavating pulmonary metastases. Am J Roentgenol Radium Ther Nucl Med 1961;85:277-293.

122. Thalinger AR, Rosenthal SN, Borg S, et al. Cavitation of pulmonary metastases as a response to chemotherapy. Cancer (Phila) 1980;46:1329-1332.

123. Rovirosa A, Salud A, Felip E, et al. Cavitary pulmonary metastases in transitional cell carcinoma of the urinary bladder. Urol Int 1992;48:102-104.

124. Shin MS, Shingleton HM, Partridge EE, et al. Squamous cell carcinoma of the uterine cervix. Patterns of thoracic metastases. Invest Radiol 1995;30:724-729.

125. Alexander PW, Sanders C, Nath H. Cavitary pulmonary metastases in transitional cell carcinoma of urinary bladder. AJR Am J Roentgenol 1990;154:493-494.

126. Charig MJ, Williams MP. Pulmonary lacunae: sequelae of metastases following chemotherapy. Clin Radiol 1990;42:93-96.

127. Lee KS, Kim TS, Fujimoto K, et al. Thoracic manifestation of Wegener's granulomatosis: CT findings in 30 patients. Eur Radiol 2003;13:43-51.

128. Ohdama S, Akagawa S, Matsubara O, Yoshizawa Y. Primary diffuse alveolar septal amyloidosis with multiple cysts and calcification. Eur Respir J 1996;9:1569-1571.

129. Essadki O, Chartrand-Lefebvre C, Finet JF, Grenier P. Cystic pulmonary metastasis simulating a diagnosis of histiocytosis X. J Radiol 1998;79:886-888.

130. Shepard J, Moore E, Templeton P, et al. Pulmonary intravas-cular tumor emboli: dilated and beaded peripheral pulmonary arteries at CT. Radiology 1993;187:797-801.

131. Kang C, Choi J, Kim H, et al. Lung metastases manifesting as pulmonary infarction by mucin and tumor embolization: radiographic, high-resolution CT, and pathologic findings. J Comput Assist Tomogr 1999;23:644-646.

132. Odeh M, Oliven A, Misselevitch I, et al. Acute cor pulmonale due to tumor cell microemboli. Respiration 1997;64:384-387.

133. Chan CK, Hutcheon MA, Hyland RH, et al. Pulmonary tumor embolism: a critical review of clinical, imaging, and hemody-namic features. J Thorac Imaging 1987;2:4-14.

134. Schriner RW, Ryu JH, Edwards WD. Microscopic pulmonary tumor embolism causing subacute cor pulmonale: a difficult antemortem diagnosis. Mayo Clin Proc 1991;66:143-148.

135. Braman SS, Whitcomb ME. Endobronchial metastasis. Arch Intern Med 1975;135:543-547.

136. Litle VR, Christie NA, Fernando HC, et al. Photodynamic therapy for endobronchial metastases from nonbronchogenic primaries. Ann Thorac Surg 2003;76:370-375.

137. Baumgartner WA, Mark JB. Metastatic malignancies from distant sites to the tracheobronchial tree. J Thorac Cardiovasc Surg 1980;79:499-503.

138. Mason AC, White CS. CT appearance of endobronchial non-Hodgkin lymphoma. J Comput Assist Tomogr 1994;18:559-561.

139. Zerhouni EA, Naidich DP, Stitik FP, et al. Computed tomography of the pulmonary parenchyma. Part 2: Interstitial disease. J Thorac Imaging 1985;1:54-64.

140. Ren H, Hruban RH, Kuhlman JE, et al. Computed tomography of inflation-fixed lungs: the beaded septum sign of pulmonary metastases. J Comput Assist Tomogr 1989;13:411-416.

141. Ikezoe J, Godwin JD, Hunt KJ, et al. Pulmonary lymphangitic carcinomatosis: chronicity of radiographic findings in long-term survivors. AJR Am J Roentgenol 1995;165:49-52.

142. Munk PL, Muller NL, Miller RR, Ostrow DN. Pulmonary lym-phangitic carcinomatosis: CT and pathologic findings. Radiology 1988;166:705-709.

143. Stein MG, Mayo J, Muller N, Aberle DR, Webb WR, Gamsu G. Pulmonary lymphangitic spread of carcinoma: appearance on CT scans. Radiology 1987;162:371-375.

144. Berkman N, Breuer R, Kramer M, Polliack A. Pulmonary involvement in lymphoma. Leuk Lymphoma 1996;20:229-237.

145. Tanaka N, Matsumoto T, Miura G, et al. CT findings of leukemic pulmonary infiltration with pathologic correlation. Eur Radiol 2002;12:166-174.

146. Heyneman LE, Johkoh T, Ward S, et al. Pulmonary leukemic infiltrates: high-resolution CT findings in 10 patients. AJR Am J Roentgenol 2000;174:517-521.

147. Johkoh T, Ikezoe J, Tomiyama N, et al. CT findings in lym-phangitic carcinomatosis of the lung: correlation with histologic findings and pulmonary function tests. AJR Am J Roentgenol 1992;158:1217-1222.

148. Honda O, Johkoh T, Ichikado K, et al. Comparison of high resolution CT findings of sarcoidosis, lymphoma, and lymphangitic carcinoma: is there any difference of involved interstitium? J Comput Assist Tomogr 1999;23:374-379.

149. Lewis E, Caskey C, Fishman E. Lymphoma of the lung: CT findings in 31 patients. AJR Am J Roentgenol 1991;156:711-714.

150. Strollo DC, Rosado-de-Christenson ML, Franks TJ. Reclassification of cystic bronchioloalveolar carcinomas to adenocar-cinomas based on the revised World Health Organization Classification of Lung and Pleural Tumours. J Thorac Imaging 2003;18:59-66.

151. Akira M, Atagi S, Kawahara M, et al. High-resolution CT findings of diffuse bronchioloalveolar carcinoma in 38 patients. AJR Am J Roentgenol 1999;173:1623-1629.

152. Wolff SD, Kuhlman JE, Fishman EK. Thoracic Kaposi sarcoma in AIDS: CT findings. J Comput Assist Tomogr 1993;17:60-62.

153. McLoud TC, Kalisher L, Stark P, et al. Intrathoracic lymph node metastases from extrathoracic neoplasms. AJR Am J Roentgenol 1978;131:403-407.

154. Chen JT, Dahmash NS, Ravin CE, et al. Metastatic melanoma in the thorax: report of 130 patients. AJR Am J Roentgenol 1981; 137:293-298.

155. Kutty K, Varkey B. Incidence and distribution of intrathoracic metastases from renal cell carcinoma. Arch Intern Med 1984; 144:273-276.

156. Williams MP, Husband JE, Heron CW. Intrathoracic manifestations of metastatic testicular seminoma: a comparison of chest radiographic and CT findings. AJR Am J Roentgenol 1987;149: 473-475.

157. Schirrmeister H, Kuhn T, Guhlmann A, et al. Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures. Eur J Nucl Med 2001;28:351-358.

158. Barranger E, Grahek D, Antoine M, et al. Evaluation of fluo-rodeoxyglucose positron emission tomography in the detection of axillary lymph node metastases in patients with early-stage breast cancer. Ann Surg Oncol 2003;10:622-627.

159. van der Hoeven JJ, Hoekstra OS, Comans EF, et al. Determinants of diagnostic performance of [F-18]fluorodeoxyglucose positron emission tomography for axillary staging in breast cancer. Ann Surg 2002;236:619-624.

160. Marel M, Zrustova M, Stasny B, et al. The incidence of pleural effusion in a well-defined region. Epidemiologic study in central Bohemia. Chest 1993;104:1486-1489.

161. Salyer WR, Eggleston JC, Erozan YS. Efficacy of pleural needle biopsy and pleural fluid cytopathology in the diagnosis of malignant neoplasm involving the pleura. Chest 1975;67:536-539.

162. Blackman NS, Rabin CB. Bilateral pleural effusion; its significance in association with a heart of normal size. J Mt Sinai Hosp NY 1957;24:45-53.

163. Monte SA, Ehya H, Lang WR. Positive effusion cytology as the initial presentation of malignancy. Acta Cytol 1987;31:448-452.

164. Sahn SA. Malignant pleural effusions. Clin Chest Med 1985; 6:113-125.

165. O'Donovan PB, Eng P. Pleural changes in malignant pleural effusions: appearance on computed tomography. Cleve Clin J Med 1994;61:127-131; quiz 162.

166. Blackmore CC, Black WC, Dallas RV, et al. Pleural fluid volume estimation: a chest radiograph prediction rule. Acad Radiol 1996; 3:103-109.

167. Moskowitz H, Platt RT, Schachar R, et al. Roentgen visualization of minute pleural effusion. An experimental study to determine the minimum amount of pleural fluid visible on a radiograph. Radiology 1973;109:33-35.

168. Castellino RA, Filly R, Blank N. Routine full-lung tomography in the initial staging and treatment planning of patients with Hodgkin's disease and non-Hodgkin's lymphoma. Cancer (Phila) 1976;38:1130-1136.

169. Filly R, Bland N, Castellino RA. Radiographic distribution of intrathoracic disease in previously untreated patients with Hodgkin's disease and non-Hodgkin's lymphoma. Radiology 1976;120:277-281.

170. Castellino RA. Diagnostic imaging evaluation of Hodgkin's disease and non-Hodgkin's lymphoma. Cancer (Phila) 1991;67: 1177-1180.

171. Das DK, Gupta SK, Ayyagari S, Bambery PK, Datta BN, Datta U. Pleural effusions in non-Hodgkin's lymphoma. A cytomor-phologic, cytochemical and immunologic study. Acta Cytol 1987; 31:119-124.

172. Kocijancic I, Vidmar K, Ivanovi-Herceg Z. Chest sonography versus lateral decubitus radiography in the diagnosis of small pleural effusions. J Clin Ultrasound 2003;31:69-74.

173. Eibenberger KL, Dock WI, Ammann ME, et al. Quantification of pleural effusions: sonography versus radiography. Radiology 1994;191:681-684.

174. Yang PC, Luh KT, Chang DB, Wu HD, Yu CJ, Kuo SH. Value of sonography in determining the nature of pleural effusion: analysis of 320 cases. AJR Am J Roentgenol 1992;159:29-33.

175. Gorg C, Restrepo I, Schwerk WB. Sonography of malignant pleural effusion. Eur Radiol 1997;7:1195-1198.

176. Bradley MJ, Metreweli C. Ultrasound in the diagnosis of the juxta-pleural lesion. Br J Radiol 1991;64:330-333.

177. Arenas-Jimenez J, Alonso-Charterina S, Sanchez-Paya J, et al. Evaluation of CT findings for diagnosis of pleural effusions. Eur Radiol 2000;10:681-690.

178. Akaogi E, Mitsui K, Onizuka M, et al. Pleural dissemination in non-small cell lung cancer: results of radiological evaluation and surgical treatment. J Surg Oncol 1994;57:33-39.

179. Aquino SL, Webb WR, Gushiken BJ. Pleural exudates and transudates: diagnosis with contrast-enhanced CT. Radiology 1994; 192:803-808.

180. Leung AN, Muller NL, Miller RR. CT in differential diagnosis of diffuse pleural disease. AJR Am J Roentgenol 1990;154:487-492.

181. Mori K, Hirose T, Machida S, et al. Helical computed tomography diagnosis of pleural dissemination in lung cancer: comparison of thick-section and thin-section helical computed tomography. J Thorac Imaging 1998;13:211-218.

182. Traill ZC, Davies RJ, Gleeson FV. Thoracic computed tomography in patients with suspected malignant pleural effusions. Clin Radiol 2001;56:193-196.

183. Aquino SL, Chen MY, Kuo WT, Chiles C. The CT appearance of pleural and extrapleural disease in lymphoma. Clin Radiol 1999;54:647-650.

184. Falaschi F, Battolla L, Mascalchi M, et al. Usefulness of MR signal intensity in distinguishing benign from malignant pleural disease. AJR Am J Roentgenol 1996;166:963-968.

185. Hierholzer J, Luo L, Bittner RC, et al. MRI and CT in the differential diagnosis of pleural disease. Chest 2000;118:604-609.

186. Carlsen SE, Bergin CJ, Hoppe RT. MR imaging to detect chest wall and pleural involvement in patients with lymphoma: effect on radiation therapy planning. AJR Am J Roentgenol 1993;160: 1191-1195.

187. Bury T, Paulus P, Dowlati A, et al. Evaluation of pleural diseases with FDG-PET imaging: preliminary report. Thorax 1997;52: 187-189.

188. Gupta NC, Rogers JS, Graeber GM, et al. Clinical role of F-18 fluorodeoxyglucose positron emission tomography imaging in patients with lung cancer and suspected malignant pleural effusion. Chest 2002;122:1918-1924.

189. Kwek B, Aquino SL, Fischman AJ. Fluorodeoxyglucose positron emission tomography and CT after talc pleurodesis. Chest 2004; 125:2356-2360.

How To Prevent Skin Cancer

How To Prevent Skin Cancer

Complete Guide to Preventing Skin Cancer. We all know enough to fear the name, just as we do the words tumor and malignant. But apart from that, most of us know very little at all about cancer, especially skin cancer in itself. If I were to ask you to tell me about skin cancer right now, what would you say? Apart from the fact that its a cancer on the skin, that is.

Get My Free Ebook


Post a comment